Browsing by Author "Kilic, M."
Now showing 1 - 8 of 8
- Results Per Page
- Sort Options
Conference Object Donor Complications Encountered Among Left Lateral Segment Live Donors(Lippincott Williams & Wilkins, 2024) Iakobadze, Z.; Vatansever, S.; Farajov, R.; Karaca, C.; Yilmaz, C.; Kilic, K.; Kilic, M.Conference Object Donor Complications Encountered Among Right Lobe Live Liver Donors(Lippincott Williams & Wilkins, 2024) Farajov, R.; Iakobadze, Z.; Vatansever, S.; Karaca, C.; Yilmaz, C.; Kilic, K.; Kilic, M.Conference Object Factors Affecting Prognosis and Outcome in Live Donor Liver Transplantation for Hepatocellular Cancer: Is There a Pattern Beyond Patient Selection Criteria?(Lippincott Williams & Wilkins, 2019) Karaca, C.; Farajov, R.; Yilmaz, C.; Iakobadze, Z.; Kilic, M.[Abstract Not Available]Article Citation - WoS: 12Citation - Scopus: 13Factors Affecting Recurrence and Survival After Liver Transplantation for Hepatocellular Carcinoma(Elsevier Science Inc, 2018-12) Yilmaz, C.; Karaca, Can; Lakobadze, Z.; Farajov, R.; Kilic, K.; Doganay, L.; Kilic, M.Introduction. Liver transplantation (LT) remains the best treatment option for hepatocellular carcinoma (HCC). Patient selection is crucial and debated ever since the emerging of the Milan criteria in 1996. As live-donor LT is being more routinely performed worldwide, numerous new and/or expansions of the original criteria have been suggested to allow more patients to benefit from this superior treatment modality. This study aims to contribute to the ever-growing data in search for better coverage of patients with acceptable outcomes. Methods. Medical recordings of 187 adult patients who underwent LT for HCC in a 6-year period were retrospectively collected. Patients were classified by Milan and University of California, San Francisco, criteria. Survival times as well as tumor, liver disease, and recurrence-related data were recorded for each patient and the outcomes were statistically analyzed. Results. Factors significantly affecting recurrence and survival were histologic differentiation, number and the size of the tumor, and the presence of vascular invasion. Serum alpha-fetoprotein levels did not significantly affect outcomes. Among the patients exceeding both of the criteria, having a total tumor size of less than 160 mm was significantly associated with better outcomes (P = .007). Conclusion. HCC patients having tumors with vascular invasion, poor differentiation, exceeding 6 in number and 160 mm in total diameter demonstrate higher recurrence rates and worse outcomes.Conference Object Live donor liver transplantation for hepatoblastoma(Lippincott Williams & Wilkins, 2019) Karaca, C.; Yilmaz, C.; Farajov, R.; Iakobadze, Z.; Kilic, M.[Abstract Not Available]Conference Object Live Donor Liver Transplantation for Type 1 Citrullinemia(Lippincott Williams & Wilkins, 2019) Karaca, C.; Iakobadze, Z.; Yilmaz, C.; Farajov, R.; Aydogdu, S.; Aksu, G.; Kilic, M.[Abstract Not Available]Conference Object Liver Transplantation for Tyrosinemia in the Nitisinone Era(Lippincott Williams & Wilkins, 2019) Karaca, C.; Yilmaz, C.; Farajov, R.; Iakobadze, Z.; Aydogdu, S.; Kilic, M.[Abstract Not Available]Conference Object Simultaneous Right Lobe Live Donor Liver Transplantation and Off-Pump Coronary Artery Bypass Grafting(Lippincott Williams & Wilkins, 2022) Farajov, R.; Iakobadze, Z.; Yilmaz, C.; Karaca, Can; Kilic, K.; Buket, S.; Narin, C.; Kilic, M.[Abstract Not Available]
